Former Gonzaga star Matt Bouldin tested positive for a banned substance and was suspended by his team in Greece as a result.
We originally reported the story on Tuesday, but Bouldin's father confirmed the news in a conversation with KREM 2 Sports on Wednesday night. He said his son is "devastated" by the news and unwittingly used a supplement sold over the counter in the U.S. that is not banned by the NBA.
KREM 2 Sports also spoke with Bouldin's agent who said, "Matt isn't the first American to have this happen to him and he won't be the last." He says Bouldin is still in Greece awaiting a hearing by the league. He's hoping to know more about that hearing as early as next week.
The Kitsap Sun says Bouldin, who was playing for Iraklis Thessaloniki, tested positive for 4-Methyl-2-Hexanamine. The drug is listed on various Internet sites as a stimulant, nasal decongestant and nutritional supplement, according to the story.
A report by Eurobasket.com says Bouldin was tested after a game against Aris Thessaloniki on December 17th. The sample showed there was an illegal substance in his blood.
Bouldin likely faces a long-term suspension, but his father said they're still waiting to hear how long it will be.
"It could be two months. It could be two years. We just don't know." He went on to say, "It was an honest mistake by Matt and it's unfortunate this happened because of ignorance."
Gonzaga head coach Mark Few told the Kitsap Sun on Monday that Bouldin is an "unbelievable guy" and "he would never do anything illegal."
Hampered by an injured hamstring, Bouldin played in ten games for Iraklis Thessaloniki this season. He was averaging 9.7 points, 1.4 assists, and 3.0 rebounds per game.